Abstract:Background/Aims: MicroRNAs play regulatory role in cardiovascular disease. MicroRNA-223 (miR-223) was found to be expressed abundantly in myocardium. TNNI3K, a novel cardiac troponin I (cTnI)-interacting and cardiac hypertrophy related kinase, is computationally predicted as a potential target of miR-223. This study was designed to investigate the cellular and molecular effects of miR-223 on cardiomyoctye hypertrophy, focusing on the role of TNNI3K. Methods: Neonatal rat cardiomyocytes (CMs) were cultured, and CMs hypertrophy was induced by endothelin-1 (ET-1). in vivo cardiac hypertrophy was induced by transverse aorta constriction (TAC) in rats. Expression of miR-223 in CMs and myocardium was detected by real-time PCR (RT-PCR). MiR-223 and TNNI3K were overexpressed in CMs via chemically modified sense RNA (miR-223 mimic) transfection or recombinant adenovirus infection, respectively. Cell size was measured by surface area calculation using fluorescence microscopy after anti-a-actinin staining. Expression of hypertrophy-related genes was detected by RT-PCR. The protein expression of TNNI3K and cTnI was determined by Western blots. Luciferase assay was employed to confirm the direct binding of miR-223 to the 3'UTR of TNNI3K mRNA. Intracellular calcium was measured by sensitive fluorescent indicator (Furo-2). Video-based edge detection system was employed to measure cardiomyocyte contractility. Results: MiR-223 was downregulated in ET-1 induced hypertrophic CMs and in hypertrophic myocardium compared with respective controls. MiR-223 overexpression in CMs alleviated ET-1 induced hypertrophy, evidenced by smaller cell surface area and downregulated ANP, alpha-actinin, Myh6 and Myh7 expression. Luciferase reporter gene assay showed that TNNI3K serves as a direct target gene of miR-223. In miR-223-overexpressed CMs, the protein expression of TNNI3K was significantly downregulated. MiR-223 overexpression also rescued the upregulated TNNI3K expression in hypertrophic CMs. Furthermore, cTnI phosphorylation was downregulated post miR-223 overexpression. Ad.rTNNI3K increased intracellular Ca2+ concentrations and cell shortening in CMs, while miR-223 overexpression significantly rescued these hypertrophic effects. Conclusion: By direct targeting TNNI3K, miR-223 could suppress CMs hypertrophy via downregulating cTnI phosphorylation, reducing intracellular Ca2+ and contractility of CMs. miR-223/TNNI3K axis may thus be major players of CMs hypertrophy. Copyright (C) 2015 S. Karger AG, Basel

MiRNA‐339‐5p Promotes Isoproterenol‐induced Cardiomyocyte Hypertrophy by Targeting VCP to Activate the Mtor Signaling

MicroRNA-34c-5p Provokes Isoprenaline-Induced Cardiac Hypertrophy by Modulating Autophagy Via Targeting ATG4B

Inhibition of Mir-146B-5p Alleviates Isoprenaline-Induced Cardiac Hypertrophy Via Regulating DFCP1.

Mir-145 Inhibits Isoproterenol-Induced Cardiomyocyte Hypertrophy by Targeting the Expression and Localization of GATA6

Mir-139-5p Inhibits Isoproterenol-Induced Cardiac Hypertrophy by Targetting C-Jun

Overexpression of Microrna-99a Attenuates Cardiac Hypertrophy

Abstract 61: Mirna-21 Targets Left Ventricular Peroxisome Proliferator-activated Receptor Alpha in a Rat Model of Type 4 Cardiorenal Syndrome

Abstract 16546: Microrna(mir)-451 Regulates Cardiac Growth and Myocardial Reactive Oxidative Species (ROS) Level Via Nrf2 and AMPK Pathways

Mir-218 Involvement in Cardiomyocyte Hypertrophy is Likely Through Targeting Rest

Long Noncoding RNA Myocardial Infarction‑associated Transcript is Associated with the Microrna‑150‑5p/p300 Pathway in Cardiac Hypertrophy.

Microrna-214 Mediates Isoproterenol-Induced Proliferation and Collagen Synthesis in Cardiac Fibroblasts

Cardiac Hypertrophy is Positively Regulated by MicroRNA-24 in Rats

The Expression Of Microrna In Adult Rat Heart With Isoproterenol-Induced Cardiac Hypertrophy

MicroRNA-223 displays a protective role against cardiomyocyte hypertrophy by targeting cardiac troponin I-interacting kinase.

Upregulation of Microrna-34A Enhances Myocardial Ischemia-Reperfusion Injury Via the Mitochondrial Apoptotic Pathway

Microrna-340-5p Functions Downstream Of Cardiotrophin-1 To Regulate Cardiac Eccentric Hypertrophy And Heart Failure Via Target Gene Dystrophin

MicroRNA-135a Inhibits Cardiac Fibrosis Induced by Isoproterenol Via TRPM7 Channel

MicroRNA-22 regulates cardiac hypertrophy and remodeling in response to stress.

Microrna-451 Protects Against Cardiomyocyte Anoxia/Reoxygenation Injury by Inhibiting High Mobility Group Box 1 Expression

MicroRNA-350 induces pathological heart hypertrophy by repressing both p38 and JNK pathways.

MiR-27a-3p/Hoxa10 Axis Regulates Angiotensin II-Induced Cardiomyocyte Hypertrophy by Targeting Kv4.3 Expression